OpenLegislation

Paragraph 3 The Medicines for Human Use (Clinical Trials) Regulations 2004I1

England and Wales

In paragraph 3(6) (membership) of Schedule 2 (additional provisions relating to ethics committees) to the Medicines for Human Use (Clinical Trials) Regulations 2004f1—

(a)

in paragraph (c) omit “and”;

(b)

after paragraph (d) add—

“(e)

Health Education England, and

(f)

the Health Research Authority.”.

Annotations

Commencement

I1

Sch. 2 para. 3 in force at 1.4.2015, see art. 1

Footnotes

f1

S.I. 2004/1031. Paragraph 3(6) was added by S.I. 2013/235.